🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This dose-ranging study is to evaluate an investigational vaccine with the ...
Status
Completed
Location
Multiple Locations
Start Date
2005-12
Trial ID
NCT00260039
The primary purpose of the study is to test the safety of HPV Vaccine in Wo...
Status
Completed
Location
Multiple Locations
Start Date
2001-12-28
Trial ID
NCT00517309
The purpose of this study is to evaluate the safety and immunogenicity of V...
Status
Completed
Location
Multiple Locations
Start Date
2007-10
Trial ID
NCT00520598
This study is to evaluate the safety, tolerability, and immune response of ...
Status
Completed
Location
Multiple Locations
Start Date
2003-10-08
Trial ID
NCT00092547
Treatments Being Tested
The study evaluates the immunogenicity, safety and tolerability of V501 in ...
Status
Completed
Location
Multiple Locations
Start Date
2006-12-11
Trial ID
NCT00411749
The purpose of this study was to evaluate the safety, efficacy, and immunog...
Status
Completed
Location
Multiple Locations
Start Date
2007-09-24
Trial ID
NCT00543543
Treatments Being Tested
The purpose of this study is to evaluate vaccine immunogenicity and how wel...
Status
Completed
Location
Multiple Locations
Start Date
2007-10
Trial ID
NCT00551187
A study to test the safety and effectiveness of Quadrivalent HPV (types 6, ...
Status
Completed
Location
Multiple Locations
Start Date
2008-12-31
Trial ID
NCT00834106
Subjects received HPV 16 L1 VLP vaccine or placebo (1:1 ratio). Endpoints i...
Status
Completed
Location
Multiple Locations
Start Date
1999-09
Trial ID
NCT00365378
Treatments Being Tested
This study will examine the safety and tolerability of octavalent Human Pap...
Status
Completed
Location
Multiple Locations
Start Date
2006-04
Trial ID
NCT00851643